Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Unconventional semi-solid cultivation enhances cytochalasins production by the Colombian fungus Xylaria sp. CM-UDEA-H199.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088663 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6750 (Electronic) Linking ISSN: 14726750 NLM ISO Abbreviation: BMC Biotechnol Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, 2001-
    • Subject Terms:
    • Abstract:
      Competing Interests: Declarations. Ethics approval and consent to participate: The biological sampling was covered by the Permiso Marco de Recolección de especímenes de especies silvestres de la diversidad biológica granted to the University of Antioquia (Colombia) in resolution 0524 of May 27, 2014. Human osteosarcoma (U-2OS) cell line was purchased from the American Type Culture Collection (ATCC) cell line code: HTB-96. All human cell lines in the cytotoxicity assay were sourced from the German Collection for Microbes and Cell cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ) with their respective reference codes included in the experimental description. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
      Fungal species of the order Xylariales, particularly those from tropical and untapped areas like the Amazon region, denote an intriguing reservoir of biodiversity and chemically varied metabolites. Based on this potential and by implementing the One Strain Many Compounds (OSMAC) approach, herein we have cultivated a Colombian Xylaria strain in several liquid, solid or semi-solid media, under different nutrient compositions and culture conditions. Metabolomic studies of Xylaria sp. CM-UDEA-H199 across these conditions led to the isolation of diverse metabolites. Six compounds were purified from rice (BRFT) cultures, identified as griseofulvin (1), xylaropyrones B/C (2/3), akolitserin (4), hypoxylin A (5), and (-)-(R)-5-(methoxycarbonyl)mellein (6). Three compounds were isolated from liquid YM cultivation: 2-hexylidene-3-methylsuccinic acid (7), its 4-methyl ester (8), and akoenic acid (9). Notably, cultivation in the newly designed semi-solid (S-BRFT) medium significantly altered the metabolome, leading to the predominant production of cytochalasins, with five derivatives (10-14) purified and structurally characterized.Among the isolated cytochalasins, compound 12 was identified as a previously undescribed natural diepoxy derivative of cytochalasin D. Structure elucidation of all isolated compounds was achieved based on their MS and comprehensive 1D/2D NMR analyses in addition to comparisons with the reported literature. Compounds 4-6, 10 and 11 revealed mild antifungal activity, while compounds (1, 5, 6, 8, 10, 11, 13 and 14) exhibited cytotoxic activity, with hypoxylin A (5) being the most potent, displaying IC 50 values in the nanomolar range. In cellulo studies revealed that the epimerization at C-5 of cytochalasin D (10) backbone, as in hypoxylin A (5), neither affected its activity nor reversibility on actin dynamics. However, the epoxylated variant of 10, cytochalasin R (14), enhanced actin activity accompanied by reduced cytotoxicity compared to 5 and 10. The occurrence of diverse epoxy-substituted cytochalasins suggests that specific biosynthetic enzymes were activated in response to the applied fermentation conditions. These findings provide a basis for further bioprocess optimization strategies aimed at enhancing cytochalasan production, a chemical class recognized for its promising bioactivities in recent decades.
      (© 2025. The Author(s).)
    • References:
      Nat Prod Rep. 2017 Nov 15;34(11):1252-1263. (PMID: 28849835)
      Bioresour Technol. 2021 Mar;323:124566. (PMID: 33390315)
      Antioxidants (Basel). 2018 May 23;7(6):. (PMID: 29789516)
      MycoKeys. 2022 Jun 14;90:85-118. (PMID: 36760420)
      Fitoterapia. 2019 Sep;137:104278. (PMID: 31351910)
      Microbiol Spectr. 2016 Nov;4(6):. (PMID: 27809954)
      Nat Prod Rep. 2018 Sep 19;35(9):992-1014. (PMID: 29774351)
      FEBS Lett. 2018 Nov;592(22):3658-3669. (PMID: 29935019)
      Clin Exp Metastasis. 2009;26(4):273-87. (PMID: 18498004)
      Chembiochem. 2002 Jul 2;3(7):619-27. (PMID: 12324995)
      Methods Mol Biol. 2012;944:79-96. (PMID: 23065609)
      Nat Rev Drug Discov. 2021 Mar;20(3):200-216. (PMID: 33510482)
      Annu Rev Genet. 2016 Nov 23;50:371-392. (PMID: 27732794)
      Phytochemistry. 2016 Dec;132:95-101. (PMID: 27745908)
      Microorganisms. 2021 May 31;9(6):. (PMID: 34073017)
      Biomolecules. 2019 Feb 19;9(2):. (PMID: 30791504)
      AMB Express. 2012 May 20;2(1):28. (PMID: 22608165)
      J Antibiot (Tokyo). 2021 Jan;74(1):1-23. (PMID: 33097836)
      Angew Chem Int Ed Engl. 2024 Apr 15;63(16):e202318505. (PMID: 38390787)
      J Nat Prod. 2024 Jul 26;87(7):1860-1871. (PMID: 39012621)
      Curr Cancer Drug Targets. 2006 May;6(3):245-56. (PMID: 16712460)
      MycoKeys. 2023 Feb 20;95:131-162. (PMID: 37251992)
      Nat Chem Biol. 2009 Jul;5(7):450-2. (PMID: 19536102)
      J Appl Microbiol. 2006 Dec;101(6):1292-300. (PMID: 17105559)
      Nat Prod Res. 2018 Jul;32(13):1525-1531. (PMID: 29022356)
      Chem Biodivers. 2012 Jul;9(7):1338-48. (PMID: 22782879)
      J Microbiol. 2011 Jun;49(3):329-39. (PMID: 21717315)
      Prog Chem Org Nat Prod. 2021;114:1-134. (PMID: 33792860)
      Nat Rev Microbiol. 2019 Mar;17(3):167-180. (PMID: 30531948)
      Fungal Genet Biol. 2019 Sep;130:107-121. (PMID: 31195124)
      Biomolecules. 2023 Aug 15;13(8):. (PMID: 37627312)
      Nat Biotechnol. 2021 Apr;39(4):462-471. (PMID: 33230292)
      J Fungi (Basel). 2023 Apr 12;9(4):. (PMID: 37108917)
      Chemistry. 2020 Oct 27;26(60):13578-13583. (PMID: 32484589)
      Mycologia. 2023 May-Jun;115(3):277-287. (PMID: 37017575)
      Org Lett. 2019 Nov 1;21(21):8756-8760. (PMID: 31644300)
      Bioorg Med Chem Lett. 2001 Aug 6;11(15):1965-9. (PMID: 11454459)
      Nat Rev Microbiol. 2013 Jan;11(1):21-32. (PMID: 23178386)
      J Cell Biol. 1981 Mar;88(3):487-91. (PMID: 6894300)
    • Contributed Indexing:
      Keywords: Actin disruption; Cytochalasins; Metabolomics; Nutrient limitation; Xylariales
    • Accession Number:
      0 (Cytochalasins)
      0 (Culture Media)
    • Publication Date:
      Date Created: 20250702 Date Completed: 20250702 Latest Revision: 20250704
    • Publication Date:
      20250704
    • Accession Number:
      PMC12220629
    • Accession Number:
      10.1186/s12896-025-00978-2
    • Accession Number:
      40598114